Latest MED Colombia News
Jul 25, 2018
MedReleaf acquires MED Colombia MedReleaf ( OTCPK:MEDFF ) has acquired MED Colombia SAS for a total consideration of €2.75M in cash. MED Colombia has permit (in Colombia) to cultivate cannabis and produce cannabis oil extracts, along with a library of cannabis genetics. The acquisition provides MedReleaf with the ability to produce low-cost, high-quality raw materials to serve its global supply chain as well as the domestic Colombian medical cannabis market.